Doctor-Patient Communication About Colorectal Cancer Screening

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Albert Einstein College of Medicine of Yeshiva University
HHC, Gun HIll and Tremont
NYC RING, Director
Virginia Commonwealth University
Information provided by (Responsible Party):
Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT01534923
First received: February 10, 2012
Last updated: January 31, 2014
Last verified: January 2014
  Purpose

The purpose of this study is to learn more about doctor-patient communication about colon cancer screening. This study will also look to see if there are differences in those who get colon cancer screening based on the discussion the doctor had with the patient.


Condition Intervention
Colorectal Cancer Screening
Behavioral: surveys

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Doctor-Patient Communication About Colorectal Cancer Screening

Resource links provided by NLM:


Further study details as provided by Memorial Sloan-Kettering Cancer Center:

Primary Outcome Measures:
  • describe doctor-patient communication about CRC screening [ Time Frame: 2 years ] [ Designated as safety issue: No ]
    screening adherence through self report. Screening adherence will be assessed by contacting the patients and asking them if they received the CRC screening test their doctor ordered at the audio recorded visit.


Secondary Outcome Measures:
  • quality of doctor-patient communication about CRC screening and low-income patients' screening outcomes. [ Time Frame: 2 years ] [ Designated as safety issue: No ]
  • examine the association between the quality of doctor-patient communication about CRC screening and low-income patients' screening outcomes [ Time Frame: 2 years ] [ Designated as safety issue: No ]
    intent to be screened (immediately after the consultation) using the item from Geller et al.25 and 2) self-efficacy for screening (immediately after consultation) in case there are few events of actual screening.


Estimated Enrollment: 225
Study Start Date: February 2012
Estimated Study Completion Date: February 2015
Estimated Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Pts having colorectal cancer screening
The target sample of this study will be approximately 200 primary care physician-patient consultations who discuss CRC screening during the course of a clinical visit. Physician and patient participants will come from primary care practices associated with the New York City Research and Improvement Networking Group (NYC RING).
Behavioral: surveys
The intervention will be the audio-recording of the physician-patient consultation, patient and doctor surveys. These audio recordings will be coded. It will also include follow-up phone calls with patients.

  Eligibility

Ages Eligible for Study:   50 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Five health centers of the NYC RING will participate in this project. All are located in underserved urban communities within the Bronx.

Criteria

Inclusion Criteria:

Physicians

  • Attending physicians or third year residents specializing in internal medicine or family medicine, as per the medical director from the clinic.
  • Clinic is based at a NYC RING-affiliated practice.
  • English speaking; Due to limited resources, we cannot have each audio recorded consultation translated therefore, the consultation needs to be in English.

Patients

  • Ages 50-75 years old, per the United States Preventive Services Task Force recommendations for screening. This will be determined by a pre-screening of medical records by the RSA.
  • Due for colorectal cancer screening at the time of the visit, ascertained through patient self-report (e.g., no colonoscopy within the past 10 years, no flexible sigmoidoscopy or barium enema within the past five years, and no FOBT within the past year).
  • Coming for either an annual physical exam or chronic care follow up visit, per patient self-report.
  • Planning to consult with the physician in English, per patient self-report. Due to limited resources, we cannot have each audio recorded consultation translated therefore, the consultation needs to be in English.

Exclusion Criteria:

  • History of colorectal cancer, per patient self-report or per EMR..
  • History of polyps being removed, per patient self-report.
  • Colonoscopy scheduled in EMR at time of screening.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01534923

Locations
United States, New York
Albert Einstein College of Medicine
Bronx, New York, United States
Hhc, Gun Hill and Tremont
Bronx, New York, United States
Sponsors and Collaborators
Memorial Sloan-Kettering Cancer Center
Albert Einstein College of Medicine of Yeshiva University
HHC, Gun HIll and Tremont
NYC RING, Director
Virginia Commonwealth University
Investigators
Principal Investigator: Jamie Ostroff, PhD Memorial Sloan-Kettering Cancer Center
  More Information

Additional Information:
No publications provided

Responsible Party: Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT01534923     History of Changes
Other Study ID Numbers: 12-017
Study First Received: February 10, 2012
Last Updated: January 31, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by Memorial Sloan-Kettering Cancer Center:
Doctor-Patient Communication
questionnaire
survey
12-017

Additional relevant MeSH terms:
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases

ClinicalTrials.gov processed this record on July 29, 2014